IGM Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid
IGM Biosciences, Inc. had Lessee, Operating Lease, Liability, to be Paid of $56.80 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-03-06
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $56.80M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $55.19M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $61.63M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $35.77M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-12-31 | $56.80M 10-K · filed 2025-03-06 |
| 2023-12-31 | $55.19M 10-K · filed 2024-03-07 |
| 2022-12-31 | $61.63M 10-K · filed 2023-03-30 |
| 2021-12-31 | $35.77M 10-K · filed 2022-03-29 |
| 2021-09-30 | $36.70M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $13.48M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $14.34M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $13.26M 10-K · filed 2021-03-30 |
| 2020-09-30 | $14.02M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $14.77M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.52M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $16.26M 10-K · filed 2020-03-26 |
| 2019-09-30 | $11.46M 10-Q · filed 2019-11-07 |